Zinterol
![]() | |
| Names | |
|---|---|
| IUPAC name
N-[5-[2-[(1,1-dimethyl-2-phenylethyl)amino]-1-hydroxyethyl]-2-hydroxyphenyl]methanesulfonamide | |
| Identifiers | |
| 37000-20-7 | |
| 3D model (Jmol) | Interactive image |
| ChEMBL | ChEMBL1243407 |
| ChemSpider | 34825 |
| ECHA InfoCard | 100.189.867 |
| 3466 | |
| MeSH | Zinterol |
| PubChem | 37990 |
| UNII | 7167N7AJJR |
| |
| |
| Properties | |
| C19H26N2O4S | |
| Molar mass | 378.49 g/mol |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| | |
| Infobox references | |
Zinterol is a beta-adrenergic agonist.[1]
Its structure is based on soterenol (antiarrhythmic) and phentermine.
References
- ↑ Heubach JF, Graf EM, Molenaar P, et al. (May 2001). "Murine ventricular L-type Ca2+ current is enhanced by zinterol via β1-adrenoceptors, and is reduced in TG4 mice overexpressing the human β2-adrenoceptor". Br. J. Pharmacol. 133 (1): 73–82. doi:10.1038/sj.bjp.0704045. PMC 1572761
. PMID 11325796.
This article is issued from Wikipedia - version of the 8/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
